SELLAS Life Sciences Group (RXK3) Short Interest
DB • RXK3 • US81642T2096
As of Nov 3, 2026, ORTEX estimated 8.5% of free float sold short, 17,221.1 days to cover, cost to borrow 7.7%. Sign up for live short interest data.
DB • RXK3 • US81642T2096
As of Nov 3, 2026, ORTEX estimated 8.5% of free float sold short, 17,221.1 days to cover, cost to borrow 7.7%. Sign up for live short interest data.
This page tracks how heavily SELLAS Life Sciences Group (DB:RXK3) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
SELLAS Life Sciences Group (DB: RXK3) has a market capitalization of $1.6B. Last close €17.35 (as of 2026-11-18); 52-week range €1.20 to €18.25. ORTEX data as of 2026-11-03: short interest was 8.5% of free float, 17,221.1 days to cover and the average cost to borrow was 7.7%. Sign up for live short interest data.